Description
Ceppra (Levetiracetam) Coated Tablets 500 mg. №60
Composition
The active ingredient in Ceppra is levetiracetam, a medication indicated for epilepsy treatment. Each tablet contains 500 mg of levetiracetam.
Mechanism of Action
Levetiracetam works by binding to synaptic vesicle protein 2A (SV2A) in the brain, which contributes to the regulation of neurotransmitter release. By modulating SV2A, levetiracetam helps stabilize neuronal excitability and prevent abnormal electrical activity that leads to seizures.
Pharmacological Properties
Levetiracetam exhibits antiepileptic properties through its selective binding to SV2A, which inhibits neurotransmitter release and modulates neuronal excitability. It has a broad spectrum of activity against various types of seizures and is well-tolerated in most patients.
Indications for Use
Ceppra is indicated for the management of partial onset seizures in both adults and children aged 1 month and older. Additionally, it is approved for the treatment of myoclonic seizures in adults and adolescents aged 12 years and above.
Contraindications
Avoid taking Ceppra if you have a documented allergy to levetiracetam or any other components present in the tablets. It is contraindicated in individuals with severe renal impairment due to the risk of drug accumulation and potential adverse effects.
Side Effects
Common side effects of Ceppra may include dizziness, drowsiness, fatigue, and behavioral changes. Some individuals may experience gastrointestinal disturbances such as nausea or vomiting. Contact your healthcare provider if you encounter persistent or severe side effects.
Usage Instructions
For adults, the typical dosage of Ceppra ranges from 1000 mg to 3000 mg daily, divided into two separate administrations. It is essential to follow your physician’s instructions meticulously. Swallow the tablets whole with a glass of water, and do not discontinue the medication abruptly without medical advice.
Advantages Over Analogues
Ceppra offers a favorable safety profile and a well-established efficacy in controlling various seizure types. Compared to some traditional antiepileptic drugs, levetiracetam is associated with fewer drug interactions and a lower incidence of significant adverse effects, making it a preferred choice for many patients.
Suitable Patient Groups
Ceppra is suitable for use in pediatric patients aged 1 month and older, as well as in elderly individuals. It is well-tolerated across different age groups, with dosing adjustments often necessary based on individual patient characteristics such as renal function and concomitant medications.
Storage and Shelf Life
Store Ceppra tablets at controlled room temperature away from moisture and light. Ensure the packaging is tightly closed to protect the medication from environmental factors. Check the expiration date on the packaging and do not use the tablets beyond this date.
Packaging Description
Ceppra tablets are typically packaged in blister packs to ensure individual tablet integrity and facilitate convenient dosing. Each box contains 60 tablets, with clear labeling of the medication name, strength, and dosage instructions for user guidance.
